PBPK models for the prediction of in vivo performance of oral dosage forms
2013 · European Journal of Pharmaceutical Sciences · 313 citations
https://doi.org/10.1016/j.ejps.2013.09.008
C
Christer Tannergren
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
52
Papers
2.7K
Citations
27
h-index
37
i10-index
Christer Tannergren is an academic researcher from Center for Global Development. The author has contributed to research in topics: Drug Solubulity and Delivery Systems & Drug Transport and Resistance Mechanisms & Analytical Methods in Pharmaceuticals. The author has an h-index of 27, co-authored 45 publications.
ORCID: 0000-0003-3897-337XPapers by this author
worksABSORPTION/METABOLISM OF SULFORAPHANE AND QUERCETIN, AND REGULATION OF PHASE II ENZYMES, IN HUMAN JEJUNUM IN VIVO
2003 · Drug Metabolism and Disposition · 221 citations
https://doi.org/10.1124/dmd.31.6.805
In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: Application of the mechanistic absorption model GI-Sim
2013 · European Journal of Pharmaceutical Sciences · 167 citations
https://doi.org/10.1016/j.ejps.2013.05.019
Transport Characteristics of Fexofenadine in the Caco-2 Cell Model
2004 · Pharmaceutical Research · 129 citations
https://doi.org/10.1023/b:pham.0000036913.90332.b1
The effect of ketoconazole on the <i>in vivo</i> intestinal permeability of fexofenadine using a regional perfusion technique
2003 · British Journal of Clinical Pharmacology · 74 citations
https://doi.org/10.1046/j.1365-2125.2003.01722.x
Increased Understanding of Intestinal Drug Permeability Determined by the LOC-I-GUT Approach Using Multislice Computed Tomography
2009 · Molecular Pharmaceutics · 35 citations
https://doi.org/10.1021/mp800145r
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat